◤ Breaking News
◤ HTAi Holiday Hours
◤Last Chance to Submit your HTAi Award Nominations!
HTAi is currently accepting submissions for two prestigious awards: the David Banta Award and the Sigrid Droste Ethics Award. Help us recognize outstanding contributions to HTA— submit your nominations today!
Submission deadline: December 15, 2024
The David Banta Award
The David Banta Award honors individuals who have made exceptional, long-lasting contributions to HTA over 25 years, impacting at least five countries. Named in honor of Dr. David Banta, a pioneer in the field of HTA, the award celebrates individuals who have demonstrated significant leadership, advanced HTA science and methodology, and supported evidence-based decision-making in health systems. Due to its prestige, this award is not given every year.
The Sigrid Droste Award
The Sigrid Droste Award was established in memory of Sigrid Droste to recognize Society members in good standing who are making or have made important contributions in ethics in HTA. Sigrid’s background and personal experience as a chronically ill individual granted her access to the existing challenges translating evidence into everyday patient care, and led her to develop a strong focus on the ethics of HTA. The Award will only be given in years when a suitable nominee(s) fulfills the Award’s eligibility criteria and is nominated by an HTAi member in good standing.
◤ HTAi Disinvestment and Early Awareness Interest Group Opens Call for Technical Officer
The Disinvestment and Early Awareness IG (DEA IG) is looking for a dedicated and enthusiastic individual who is willing to provide one to two days a month to support its Co-Chairs and Steering Committee as a Technical Officer (TO), from January to December 2025 (subject to a positive evaluation by the IG Chairs, the contract may be extended for additional 12 months).
Examples of responsibilities include defining agendas, setting calls and taking minutes, writing reports, supporting project work and scientific papers, drafting press releases and other similar activities.
Applications must be received by December 15, 2024. For more information about the opportunity, click the button below.
◤ HTAi Policy Forum Advisory Committee Opens Call for Nominations
The Policy Forum Advisory Committee (PFAC) has opened a call for nominations to fill one (1) For-Profit vacancy and one (1) Not-For-Profit vacancy.
The PFAC is an umbrella committee aligned with the strategic direction of the Society to review the operating models within and between the forum series. The Committee meets 4 times per year (1.5-hour meetings) via teleconference (Zoom). The current Chair of the committee is Dr. Iñaki Gutierrez-Ibarluzea, with support from the HTAi Secretariat.
New members can be nominated by current or outgoing PFAC committee members or a member of the HTAi Board of Directors. Please send nominations by email no later than Wednesday, December 18, 2024.
For more information about the opportunity, click the button below.
◤ HTAi Policy Forum Organizing Committees Open Calls for Members
The HTAi is seeking members to fill vacancies on the Global, Asia, and Latin America Policy Forum Organizing Committees:
- The Latin America Policy Forum Organizing Committee has opened a call for nominations to fill one (1) For-Profit and one (1) Not-for-Profit vacancy.
- The Asia Policy Forum Organizing Committee has opened a call for nominations to fill one (1) Not-For-Profit vacancy.
- The Global Policy Forum Organizing Committee has opened a call for nominations to fill one (1) For-Profit vacancy.
Please send nominations by email to the Policy Forum team no later than Wednesday, January 8, 2025, indicating the intended Organizing Committee.
◤ HTAi Middle East and North Africa Regional Meeting Postponed to Late 2025
We wish to thank everyone who has shown interest in the upcoming HTAi Middle East and North Africa (MENA) Regional Meeting and expressed a willingness to contribute to this important event.
After careful consideration of several factors, the meeting, originally scheduled for April 24–25, 2025, has been postponed to Q3 or Q4 of next year. This decision reflects our commitment to delivering a highly impactful and successful event focused on advancing HTA in the region.
Updates on the meeting’s progress and confirmed details will be shared in the coming weeks. We appreciate your understanding while further details emerge. Together, we aim to make this event a pivotal moment for HTA in the MENA region.
◤ Updates from the HTAi 2025 Annual Meeting
The 2025 HTAi Annual Meeting will will take place June 14-18, 2025, in the incredible city of Buenos Aires— mark your calendars and save the date!
The meeting will discuss topics related to the central theme, NextGen Evidence: Diversifying and Advancing HTA to Meet Global Demands. Read more on the theme here.
Registration for the HTAi 2025 Annual Meeting in Buenos Aires will Open in January
Get a head start on your travel plans for #HTAi2025! Visit the Annual Meeting website for essential travel and entry details for Argentina, including visa types and requirements, ensuring a smooth journey.
In the meantime, check out this video from our local host organization, IECS – Institute for Clinical Effectiveness and Health Policy for a glimpse of what to expect at the HTAi 2025 Annual Meeting.
Discover the Venue
The 2025 Annual Meeting takes place at the Sheraton Buenos Aires Convention Centre, located within the Sheraton Buenos Aires Hotel. One of Argentina’s premier event spaces, the Convention Centre spans an impressive 5,145 square meters and features 22 versatile event spaces, ready to host an unforgettable gathering.
Get ready to join us in beautiful Buenos Aires!
◤ Renew your HTAi Membership Today!
HTAi membership renewals are open, inviting current members to continue their engagement with our global community dedicated to advancing HTA. Renewal notices have been sent to current Individual members and organizational representatives with detailed renewal instructions, ensuring a smooth process to maintain access to HTAi’s exclusive resources, events, and opportunities.
All 2024 membership expire December 31, 2024. If you have not received your renewal notice, please contact the Secretariat at info@htai.org.
Thank you for your ongoing commitment to our shared mission of supporting effective, evidence-based health policies worldwide!
◤ A Look Back
◤ HTAi Webinar | Challenges of Assessing Digital Health Technologies in LMICs
On November 29, 2024, the HTAi HTA in Developing Countries Interest Group hosted a webinar discussing the challenges in capturing global and local factors associated with digital health technologies (DHTs) using current approaches in Health Technology Assessment. Speakers present their experience with DHTs in their countries, including the EDiHTA project. Challenges and future perspectives were important topics.
◤ HTAi Webinar | HTAi Scholarships: Opportunities, Experiences and Challenges
On October 31, 2024, the HTAi HTA in Developing Countries Interest Group hosted a webinar during which HTAi Scholarship Recipients, Members, and Team shared their projects and experiences related to the scholarship program and the challenges to early careers in HTA.
◤ Network News
◤ Upcoming Webinar: A renewed HTA competency framework: reflections from HTA MSc programs around the globe
Join leading experts in Health Technology Assessment (HTA) for a comprehensive webinar exploring the development of HTA competencies and insights from prestigious HTA Master’s programs around the world. This session will provide a global perspective on HTA education and how the evolving competency framework is shaping the future of health systems.
This webinar will take place December 10, 2024 at 14:00 CET.
Register to join us!
◤ HTAi Interest Group Feature: Rare Diseases Interest Group
HTAi Interest Groups (IGs) serve as vibrant professional and scientific communities that unite individuals from healthcare, business, government, academia, and consulting, all committed to advancing HTA. Open to all HTAi members, these groups provide a valuable platform for networking, sharing insights, and collaborating on initiatives that shape the future of HTA.
The HTAi Rare Diseases Interest Group (RDIG) is a service to members who have interest in HTA of health technologies for rare diseases. This Interest Group is dedicated to sharing good practices in evidence generation for rare disease technologies (RDTs), fair assessment processes that take account of the feasibility of evidence generation and appraisal processes that take account of the burden of rare diseases on patients and society when determining value.
Watch the video below to learn how you can benefit from joining the HTAi Rare Diseases Interest Group.
◤ Join the SUSTAIN-HTA Delphi Study: Help Develop an HTA Competency Framework with Three Levels of Expertise
The SUSTAIN-HTA consortium aims to develop a generic competency framework for Health Technology Assessment (HTA) expertise on three levels of expertise. HTAi is supporting this project. We are excited to announce a two-round Delphi study as part of the SUSTAIN-HTA project which aims to upskill the pan-European HTA body workforce and harmonize HTA expertise.
Who should participate?
We are calling on a broad range of stakeholders with at least three years of professional expertise in HTA, or at least 3 years of educational expertise related to HTA.
How to participate?
Please use this link to access the Delphi survey where you can submit your valuable inputs. Completing the survey takes approximately 30 to 45 minutes. The first round closes December 9th, 2024. Please use this link to access the information sheet for more information.
Why participate?
Your participation will directly influence the description of the three levels in the competency framework for HTA expertise, impacting HTA education and expertise.
We look forward to your contributions to shape the future of HTA!
If you have any questions, please reach out to Dr. Wija Oortwijn, work package lead SUSTAIN-HTA at w.oortwijn@radboudumc.nl.
◤ HTA News from Around the World
- Canada’s Drug Agency opens launches consultation on methods guide.
Read more
- Canada’s Drug Agency opens launches consultation on methods guide.
- Australia’s health minister announces advisory group to guide the government’s response to the HTA Review final report, PBAC responds.
Read more
- Australia’s health minister announces advisory group to guide the government’s response to the HTA Review final report, PBAC responds.
- European Commission announces new commissioners, including Commissioner for Health and Animal Welfare.
Read more
- European Commission announces new commissioners, including Commissioner for Health and Animal Welfare.
- New report from WHO shows need for sustained investment in infection prevention and control programs.
Read more
- New report from WHO shows need for sustained investment in infection prevention and control programs.
- Senegal and Rwanda achieve WHO Maturity Level 3 in medicines regulation, becoming the seventh and eighth countries in Africa to receive the designation.
Read more
- Senegal and Rwanda achieve WHO Maturity Level 3 in medicines regulation, becoming the seventh and eighth countries in Africa to receive the designation.
◤ IJTAHC Featured Publications
- Impact of COVID-19 pandemic on HTAsiaLink network members.
Read more
- Impact of COVID-19 pandemic on HTAsiaLink network members.
- Health technology assessment framework for artificial intelligence-based technologies.
Read more
- Health technology assessment framework for artificial intelligence-based technologies.
- Impact of indication changes on scoping for European Union Joint Clinical Assessment: scale of the problem and how to address it.
Read more
- Impact of indication changes on scoping for European Union Joint Clinical Assessment: scale of the problem and how to address it.
◤ Bulletin Board
Health Technology Wales seeks Chair for Appraisal Panel: Health Technology Wales is seeking a highly experienced and knowledgeable care professional to support the development of national guidance on innovative health and care technologies in Wales by chairing the HTW Appraisal Panel.
Learn more
- Utrecht University Department of Pharmaceutical Sciences seeks Junior Researcher in HTA: Join the research team and play a key role in implementing the new EU Health Technology Assessment Regulation across three EU member states.
Learn more
- Utrecht University Department of Pharmaceutical Sciences seeks Junior Researcher in HTA: Join the research team and play a key role in implementing the new EU Health Technology Assessment Regulation across three EU member states.